Applying for a NSW Authority to Possess or Supply Schedule 8 or Schedule 9 substances

This article outlines the procedures for applying for a NSW Authority to Possess or Supply Schedule 8 or Schedule 9 substances, Prohibited Drugs/Plants for the Purpose of Research, Instruction, Analysis or Treatment of Animals.

You must hold or be listed as an authorised user on an authority issued through NSW Health Pharmaceutical Services to work with Schedule 8 or 9 drugs.

Information on Importing or Exporting scheduled drugs is included below.

Schedule 8 and 9 Drugs being used in Clinical Trials require different forms and governance processes, please contact clinical-trials.research@sydney.edu.au for advice.

For any queries in relation to schedule drug processes and procedures, including work occurring outside NSW, please contact: scheduled.drugs@sydney.edu.au

The expectations for working with scheduled drugs at the University can be found in the Management of drugs in laboratory and animal-based research procedures 2024.

What are some tips for using the eNotebook?

When using the eNotebook, knowing about certain features and practices can enhance your experience and help you manage your research data more easily.

Making the most of your Non-Traditional Output (NTRO) research statement

Research content for a Non-Traditional Research Output (NTRO) is often not apparent in the output itself. A Research Statement demonstrates that your NTRO meets both the definition of research and the criteria for the specific type of NTRO. You will need to provide a research statement when reporting most types of NTROs.

IRMA-ORCID Integration project - overview

This article provides an overview of the IRMA-ORCID system integration project, and benefits of registering for an ORCID profile.

The University’s Integrated Research Management Application (IRMA) captures publication data, research grants and contracts, and human and animal ethics applications.

The Research Portfolio and ICT have implemented a system integration between IRMA and ORCID to enable automated updates of research outputs to researcher ORCID profiles.  

The project has also incorporated development of BibTex export functionality from IRMA, enabling more streamlined export of publication data not included in the integration.

 

Project information and support ORCID identifier: Enhancing your global presence

NHMRC Synergy Grant 2021 for 2022

The NHMRC Synergy Grants support outstanding multidisciplinary teams of investigators to work together to answer major questions that cannot be answered by a single investigator.

How to initiate a Confidentiality Agreement (self-service)

Confidentiality Agreement (self-service) webform allows the auto-generation of a simple, fair contract for the exchange of low risk confidential information (excluding research data) with one other organisation for a nominated purpose.

How to submit an Authority To Submit (ATS) form

The Authority To Submit (ATS) facilitates written confirmation of Faculty support for a research grant to be submitted from relevant delegates who have authority for financial and other resource allocation. An ATS is required for all research grants that a University of Sydney staff member is named on. This includes applications that will not be administered by the University of Sydney (non-lead applications), as well as applications that will be administered by the University of Sydney (lead applications).  The ATS, with all required approvals, must be completed before the application can be submitted to the funder.

A digital version of the old ATS form is implemented in ServiceNow with an automated workflow to collect approvals and document the process under an overarching Funding submission record. This article aims to assist researchers in submitting the form. 

Note: the digital ATS will only be required for the grant opportunities listed below. For all other opportunities, the paper-based form (pdf) will be required.

IRMA-ORCID Integration - Frequently asked questions

This article aims to provide answers to some commonly asked questions about the IRMA-ORCID Integration.

  • IRMA-ORCID integration processes

  • Managing your ORCID profile

Project information and support ORCID identifier: Enhancing your global presence

The University implementation is scheduled for roll-out in June 2022. 
Support documentation will be updated as the functionality is fully implemented.

Disposal and destruction process for scheduled drugs

This article outlines the procedures for disposal of empty or partial containers of scheduled drugs used in laboratory or animal based research.

Expired, contaminated or unwanted drugs should be disposed of in a timely manner.

Schedule 4D, Schedule 8 and Schedule 9 drugs have strict requirements for destruction and must be disposed of following the process below.

All drugs, including dilutions and small amounts remaining from procedures, must be disposed of safely and should never be tipped down the sink.

Clinical trial drugs should follow their validated disposal process when it is included in one of the clinical trial’s essential documents e.g. protocol, otherwise requests to dispose of drugs can be submitted via the Clinical medicine disposal process. Researchers should maintain records that document the system for disposal and the destruction of the product/s.

For any queries in relation to schedule drug processes and procedures, or disposal/destruction advice for other facilities/campuses, please contact: scheduled.drugs@sydney.edu.au

How do I manage my research data?

Research data is a valuable resource that needs to be managed optimally to ensure its integrity and security, to realise its collaborative potential, and to meet legislative and policy requirements.

NHMRC Investigator Grants 2021 for 2022

The NHMRC Investigator Grants consolidate separate fellowship and research support into one grant scheme that provides the highest-performing researchers at all career stages with funding for their salary (if required) and a significant research support package. 

These grants provide the investigator with flexibility to pursue important new research directions as they arise and to form collaborations as needed, rather than being restricted to the scope of a specific research project. 

Disposal of clinical medications

Clinical trial medications should follow their validated disposal process when it is included in one of the clinical trial’s essential documents e.g. protocol, otherwise requests to dispose of drugs can be submitted via the processes outlined below.

Researchers should maintain records that document the system for disposal and the destruction of the product/s.

For items that require a destruction certificate, a work request must first be raised in CampusAssist to obtain a quote.

Bulk University Health Clinic* medications should be disposed of via the University hazardous waste program (Schedule 2, 3, 4) following this process. For indivdual or a small number of barcoded containers (eg < 10), please contact your local TSS Technical Officer. 

If a disposal request involves S4D, S8 or S9 products, please email scheduled.drugs@sydney.edu.au before completing any processes.

*Clinics as per the definition in the Health Clinics and Clinical Services Policy 2020

Project Budgeting Tool - Indirect Cost Recovery Video

This video should answer questions specific to value pricing concept and Indirect Cost Recovery (ICR) related to the Project Budgeting Tool.

Transport of scheduled drugs

This article outlines the procedures for transporting high risk scheduled drugs: Schedule 4D (S4D), Schedule 8 (S8) and Schedule 9 (S9).

If S4D, S8 or S9 drugs are stolen or lost (including spills and breakages), the reporting process must immediately be followed.

All drugs and medicines need to be managed to prevent access to non authorised users.

Transport of any drug/medication should follow the principles of this guide.

For any queries in relation to schedule drug processes and procedures, please contact: scheduled.drugs@sydney.edu.au

Planning for publication of a Non-Traditional Research Output (NTRO)

To ensure your NTRO will be eligible for inclusion in the annual Sydney Research Collection and in the University’s ERA submission, as well as counting towards your annual academic performance, it pays to plan ahead for the publication of your NTRO.

Principles of Research Data Management

The value of research data increases when it is ability to be accessed, shared and stored is optimised. Maximise the value of your research data through meeting the principles of research data management.

Ordering medicines and drugs for use in University Health Clinics

MyLab is used to purchase and manage medicines and drugs in clinics at the University.

This article provides steps on how to:

  • Order medicines and drugs for use in University Health Clinics*
  • Check the status of an order
  • Transfer barcodes to restricted spaces in MyLab

New users of MyLab need to request access. Guides, contact information and online training can be found on the MyLab Intranet page.

Disposal of unwanted medicines or drugs used in clinics occurs through hazardous waste. Ensure you also dispose of MyLab barcodes for any empty containers to keep your inventory accurate. Refer to the disposal guide for both processes.

For Clinical Governance queries contact ClinGov.Office@sydney.edu.au.

*Clinics as per the definition in the Health Clinics and Clinical Services Policy 2020

Pages: